Dietary Intervention and Gastrointestinal Function in Patients With Parkinson's Disease
MED
2 other identifiers
interventional
8
1 country
1
Brief Summary
In this prospective, intervention study, participants with diagnosed Parkinson's disease will be instructed to follow a Mediterranean diet for five weeks. Gut permeability will be assessed using food-grade sugar molecules. Participants will provide urine and stool samples to assess gut permeability and microbial communities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Apr 2019
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2019
CompletedFirst Posted
Study publicly available on registry
February 22, 2019
CompletedStudy Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2021
CompletedMay 4, 2021
May 1, 2021
7 months
February 21, 2019
May 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastroduodenal Permeability
The primary outcome is the change in gastroduodenal permeability induced by the Mediterranean diet. Gastroduodenal permeability will be assessed by measuring sucrose concentration in the 0 to 5-hour urine collection (end of intervention minus baseline)
Week 1; Week 5
Secondary Outcomes (6)
Small Intestinal Permeability
Week 1; Week 5
Colonic Permeability
Week 1; Week 5
Whole Gut Permeability
Week 1; Week 5
Stool Frequency
Week 1; Week 5
Stool Consistency
Week 1; Week 5
- +1 more secondary outcomes
Study Arms (1)
Mediterranean Diet
EXPERIMENTALParticipants will be given individualized diet education on the Mediterranean diet and instructed to follow the diet for the 5-week intervention period. Individualized diet education will be administered by a licensed, registered dietitian nutritionist (RDN) followed by weekly phone calls to ensure compliance, improve adherence to the diet and monitor for adverse events.
Interventions
Participants will be instructed to include the following in their diet: a) abundant use of olive oil for cooking and dressing dishes; b) consumption of ≥2 daily servings of vegetables; c) ≥2-3 daily serving of fresh fruits (including natural juices); d) ≥3 weekly servings of legumes; e) ≥3 weekly servings of fish or seafood (at least one serving of fatty fish); f) ≥3 weekly serving of nuts or seeds; g) select white instead of red meats or processed meats (burgers, sausages); h) cook at least twice a week with a tomato herb sauce. Participants will be instructed to eliminate or limit the consumption of the following foods: cream, butter, margarine, cold meat, paté, duck, carbonated and/or sugared beverages, pastries, industrial bakery products and desserts, French fries or potato chips, and out-of-home pre-cooked cakes and sweets. For usual drinkers, the main source of alcohol should be wine.
Eligibility Criteria
You may qualify if:
- Physician-diagnosed Parkinson's disease aged 21-85 years
- Hoehn \& Yahr stage \<3
- Currently living in the same household with a healthy spouse/partner who meets study eligibility criteria and is willing to participate
- Willing and able to complete informed consent in English
- Willing to complete daily and weekly questionnaires and 6 dietary recalls over approximately 7 weeks
- Willing to avoid beer, wine, and cocktails on the day before and the day of the sugar probe tests.
- Willing to provide urine and stool samples during the study collection periods.
- Willing and able to fast (no food or drink, except water or tea) for a prolonged period of time during study urine collections.
- Willing to maintain usual diet through the pre-baseline period
- Willing to make dietary changes to follow a Mediterranean dietary pattern during the intervention period.
- Willing to discontinue taking prebiotic, fiber, probiotic, herbal, or high-dose vitamin or mineral supplements that may impact inflammation during the pre-baseline period and throughout the study protocol.
- Willing to limit use of oral laxative medication to an "as-needed basis" (i.e. \<3 times per week) during the full length of the study
- Willing to avoid high intensity exercises two days prior to and the day of the permeability tests. These tests will be done on two occasions.
- Willing to provide a social security number to receive study payment.
You may not qualify if:
- Does not meet above criteria
- Atypical or secondary Parkinsonism
- History of deep brain stimulation
- Daily use of NSAIDs in the last 3 months or incidental use in the last 2 weeks prior to screening.
- Daily use of anticholinergics or prokinetic agents
- Use of enemas or suppositories to alleviate constipation
- Use of another investigational product within 3 months of the screening visit.
- Antibiotic use within 2 months from the day of stool collection
- Good adherence to the Mediterranean diet during the pre-baseline period (score \>6) based on the 14-item Mediterranean Diet Assessment Tool
- Physician-diagnosed gastrointestinal disease or condition (such as ulcerative colitis, Crohn's disease, gastroparesis, cancer, peptic ulcer disease, Celiac disease, short bowel disease, ileostomy, colostomy) other than gastroesophageal reflux or diverticular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
Related Publications (1)
Rusch C, Beke M, Tucciarone L, Nieves C Jr, Ukhanova M, Tagliamonte MS, Mai V, Suh JH, Wang Y, Chiu S, Patel B, Ramirez-Zamora A, Langkamp-Henken B. Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study. Front Neurol. 2021 Dec 23;12:794640. doi: 10.3389/fneur.2021.794640. eCollection 2021.
PMID: 35002935DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bobbi Langkamp-Henken, PhD, RD
Univeristy of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2019
First Posted
February 22, 2019
Study Start
April 15, 2019
Primary Completion
November 13, 2019
Study Completion
May 3, 2021
Last Updated
May 4, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share